Harrow, Inc. (HROW)
NASDAQ: HROW · Real-Time Price · USD
33.32
+0.46 (1.40%)
At close: Jun 3, 2026, 4:00 PM EDT
33.13
-0.19 (-0.57%)
Pre-market: Jun 4, 2026, 4:23 AM EDT
Harrow Revenue
Harrow had revenue of $44.20M in the quarter ending March 31, 2026, a decrease of -7.59%. This brings the company's revenue in the last twelve months to $268.68M, up 26.22% year-over-year. In the year 2025, Harrow had annual revenue of $272.30M with 36.41% growth.
Revenue (ttm)
$268.68M
Revenue Growth
+26.22%
P/S Ratio
4.62
Revenue / Employee
$720,308
Employees
373
Market Cap
1.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 272.30M | 72.69M | 36.41% |
| Dec 31, 2024 | 199.61M | 69.42M | 53.32% |
| Dec 31, 2023 | 130.19M | 41.60M | 46.95% |
| Dec 31, 2022 | 88.60M | 16.12M | 22.24% |
| Dec 31, 2021 | 72.48M | 23.61M | 48.30% |
| Dec 31, 2020 | 48.87M | -2.29M | -4.48% |
| Dec 31, 2019 | 51.17M | 9.79M | 23.67% |
| Dec 31, 2018 | 41.37M | 14.60M | 54.52% |
| Dec 31, 2017 | 26.77M | 6.83M | 34.26% |
| Dec 31, 2016 | 19.94M | 10.23M | 105.25% |
| Dec 31, 2015 | 9.72M | 8.06M | 485.30% |
| Dec 31, 2014 | 1.66M | -8.34M | -83.40% |
| Dec 31, 2013 | 10.00M | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | - | - | - |
| Dec 31, 2007 | - | - | - |
| Dec 31, 2005 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bausch Health Companies | 10.53B |
| Perrigo Company | 4.18B |
| Phibro Animal Health | 1.50B |
| ANI Pharmaceuticals | 923.71M |
| Evotec SE | 859.03M |
| Collegium Pharmaceutical | 796.33M |
| Pacira BioSciences | 734.86M |
| Alvotech | 562.04M |
HROW News
- 20 hours ago - Harrow Transcript: 46th Annual William Blair Growth Stock Conference - Transcripts
- 20 hours ago - Harrow Slides: 46th Annual William Blair Growth Stock Conference - Filings
- 7 days ago - Harrow to Present at William Blair's 46th Annual Growth Stock Conference - GlobeNewsWire
- 19 days ago - Harrow CEO buys $302K, CFO buys $104.7K in common stock - TheFly
- 20 days ago - Harrow price target lowered to $60 from $65 at B. Riley - TheFly
- 21 days ago - Harrow price target lowered to $88 from $91 at Cantor Fitzgerald - TheFly
- 22 days ago - Harrow Earnings Call Transcript: Q1 2026 - Transcripts
- 22 days ago - Harrow Earnings release: Q1 2026 - Filings